• OPEN AN ACCOUNT
Indian Indices
Nifty
26,068.15 -124.00
(-0.47%)
Sensex
85,231.92 -400.76
( -0.47%)
Bank Nifty
58,867.70 -480.00
( -0.81%)
Nifty IT
36,885.35 -157.95
( -0.43%)
Global Indices
Nasdaq
46,275.21 501.96
(1.10%)
Dow Jones
6,624.30 64.54
(0.98%)
Hang Seng
48,653.14 -1,170.80
(-2.35%)
Nikkei 225
9,535.95 8.30
(0.09%)
Forex
USD-INR
88.67 0.16
(0.19%)
EUR-INR
102.19 -0.14
(-0.14%)
GBP-INR
115.88 -0.12
(-0.10%)
JPY-INR
0.56 0.00
(-0.65%)

EQUITY - MARKET SCREENER

Concord Drugs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
538965
INE858L01010
34.4189
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
146.04
78.86
EPS(TTM)
Face Value()
Div & Yield %
0.54
10
0
 

l&t finance ltd
Vodafone Idea reports consolidated net loss of Rs 5524.20 crore in the September 2025 quarter
Nov 11,2025
Net Loss of Vodafone Idea reported to Rs 5524.20 crore in the quarter ended September 2025 as against net loss of Rs 7175.90 crore during the previous quarter ended September 2024. Sales rose 2.30% to Rs 11169.60 crore in the quarter ended September 2025 as against Rs 10918.20 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales11169.6010918.20 2
OPM %41.9541.67 -
PBDT2.60-1764.10 LP
PBT-5564.90-7168.10 22
NP-5524.20-7175.90 23